World news, news around town, tech update 3
Ad
Sunday, 14 July 2019
GSK's ovarian cancer treatment meets main goal in late-stage study
GlaxoSmithKline said on Monday a late-stage study testing Zejula as a maintenance therapy in patients with first-line ovarian cancer showed positive headline results.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment